Halozyme Therapeutics

HALO

HALO
Halozyme Therapeutics Stock Quote
$20.93 -$0.19 -0.9%
Price as of February 19, 2020, 10:53 a.m. EST View Interactive HALO Charts

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Interactive Chart


News & Analysis: Halozyme Therapeutics

The Fool has written over 100 articles on Halozyme Therapeutics.

All

Market Moves

Earnings









3 Monster Stocks in the Making

Halozyme Therapeutics, FMC Corp., and Braskem all have major opportunities in front of them that could lead to outsize returns.